IBT Press Releases
You can also visit the market news section of the London Stock Exchange website to view IBT press releases including NAV releases.
2009
- 20 November 2009 - Annual Information Update
- 17 November 2009 - Portfolio Company Update - Affinium Pharmaceuticals
- 16 November 2009 - Portfolio Company Update - Entellus Medical
- 9 November 2009 - Portfolio Company Update - Allocure
- 5 November 2009 - Portfolio Company Update - Delenex Therapeutics
- 2 November 2009 - Portfolio Company Update - Ricerca
- 30 October 2009 - Voting Rights and Capital
- 26 October 2009 - Portfolio Company Update - Itero Pharmaceuticals Oxagen and Ricerca
- 23 October 2009 - Annual Reports & Accounts
- 19 October 2009 - Portfolio Company Update - Lux Biosciences
- 7 October 2009 - Portfolio Company Update - TransEnterix
- 30 September 2009 - Portfolio Update - Lux Biosciences
- 28 September 2009 - Portfolio Update - Entellus
- 14 September 2009 - Portfolio Update - Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG
- 28 August 2009 - Portfolio Update - Archemix
- 27 August 2009 - Portfolio Company Update
- 26 August 2009 - Portfolio Company Update
- 7 August 2009 - Appointment of Director
- 3 August 2009 - Portfolio Company Update - Cadent
- 17 July 2009 - Portfolio Company Update - Ricerca Biosciences
- 9 July 2009 - Interim Management Statement for the Quarter ended 31 May 2009
- 2 July 2009 - Portfolio Company Update - Itero Pharmaceuticals
- 9 June 2009 - Portfolio Company Update - Micromet
- 3 June 2009 - Portfolio Company Update - Lux Biosciences
- 1 June 2009 - Follow on investment in the UK based unquoted portfolio company RespiVert - Lux Biosciences
- 11 May 2009 - VNUS Medical Technologies announced it had signed a definitive agreement with Covidien
- 24 April 2009 - Revalution of unquoted portfolio company - Ricerca Biosciences
- 20 April 2009 - IBT Interim Results
- 6 April 2009 - Follow on investment in the unquoted portfolio company ESBATech.
- 2 March 2009 - Change of Company Secretary and Registered Office
- 19 February 2009 - Investment in unquoted portfolio company TransEnterix Inc.
- 11 February 2009 - Revaluations of unquoted portfolio company Cadent
- 6 February 2009 - Revaluations of unquoted portfolio companies Affibody, Dynogen, Ricerca and Intranasal
- 26 January 2009 - Interim Management Statement
2008
- 24 December 2008 - Archemix announces a worldwide strategic alliance with GlaxoSmithKline
- 15 December 2008 - Revaluation of Unquoted Portfolio Company Affibody
- 19 November 2008 - Archemix signed a definitive merger agreement with NitroMed
- 22 October 2008 - Valuation of Unquoted Companies Cadent and Genosis
- 10 October 2008 - Valuation of Unquoted Companies Lux Biosciences and Ricerca
- 31 July 2008 - Unquoted Valuation Dynogen Written Down
- 28 July 2008 - Portfolio Company Update Acambis
- 23 July 2008 - Valuation of Unquoted Companies Lux Biosciences and Ricerca
- 21 July 2008 - Barr Pharmaceuticals announced it has signed a definitive agreement with Teva
- 15 July 2008 - Interim Management Statement for the Quarter ended 31 May 2008
- 11 July 2008 - New Investment Unquoted portfolio company CR LLC
- 2 July 2008 - New Investment Allocure
- 11 June 2008 - IBT Interim Report Submitted to UK Listing Authority
- 20 May 2008 - Private portfolio revaluation - Intranasal Therapeutics
- 24 April 2008 - Private portfolio valuation changes
- 15 April 2008 - IBT Interim Results
- 7 March 2008 - New Unquoted Investment - Vantia Limited
- 18 January 2008 - Interim Management Statement for the Quarter ended 30 November 2007
Click here for IBT press releases from 2001 - 2007
You will need Adobe Acrobat Reader to view these PDF files. If you do not have this software installed on your computer, you can download it free from the Adobe website.